文献速递牙体牙髓病

自身免疫性肝病使用免疫抑制剂患者根尖周炎患病率横断面研究

Prevalence of Apical Periodontitis in Patients with Autoimmune Liver Diseases on Immune Suppressants and Immune Modulators: A Cross-sectional Study.
PubMed 文献 · J Endod · 2024-03-26

本研究为横断面研究,比较46例接受糖皮质激素、硫唑嘌呤和/或熊去氧胆酸治疗的自身免疫性肝病(ALD)患者(1186颗牙)与50例健康对照(1251颗牙)的根尖周炎(AP)患病率。结果显示ALD组AP患病率在患者水平(P = .019)和牙水平(P = .014)均显著低于对照组;吸烟和年龄与AP增加相关。

要点

  • ALD使用免疫抑制剂患者AP患病率在患者和牙水平均显著低于健康对照。
  • 吸烟与年龄在两组中均与AP显著增加相关。
  • 两组中已行根管治疗的牙AP患病率均更高。

核心结论

  • 在观察性研究的局限下,接受免疫抑制剂(常联用免疫调节剂)治疗的自身免疫性肝病患者AP患病率较低。

研究设计与样本

  • 横断面研究,ALD组46例(男11、女35,平均年龄57.9 ± 11.8岁)共1186颗牙。
  • 对照组50例健康未用药者(男15、女35,平均年龄58.6 ± 10.4岁)共1251颗牙。
  • 记录人口学、内科、用药及牙科病史,行牙科与影像学检查。

主要发现

  • ALD组AP患病率在患者水平(P = .019)和牙水平(P = .014)均显著低于对照组。
  • 吸烟和年龄在病例与对照中均与AP显著增加相关(P = .045和P = .001)。
  • 两组中根管治疗牙的AP患病率均更高。

关键数值与推荐

  • 评估指标包括AP存在、根尖指数评分、龋失补牙数、修复体质量及根管治疗情况。
  • 同时检验患者所服药物对AP患病率的影响。

临床怎么用

  • 对ALD长期使用免疫抑制剂的患者进行根尖周状况评估时,可考虑其AP患病率可能低于一般人群。
  • 吸烟与年龄是AP的重要相关因素,临床应纳入风险评估。
  • 根管治疗牙在两组中AP患病率均更高,需重点关注其根尖周随访。

局限性

  • 研究为观察性设计,结论受其固有局限影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autoimmune liver diseases (ALDs) are chronic conditions generated by an immune-mediated autoaggressive inflammatory reaction in genetically susceptible individuals. The purpose of this study was to evaluate the prevalence of apical periodontitis (AP) in patients suffering from ALDs undergoing treatment with the immune suppressants glucocorticoids, azathioprine, and/or ursodeoxycholic acid. METHODS: The ALD group included 46 patients (11 men and 35 women, average age = 57.9 ± 11.8 years) and 1186 teeth. The control group included 50 healthy patients not taking any medications (15 men and 35 women, average age = 58.6 ± 10.4 years) and 1251 teeth. Demographic data and medical, pharmacologic, and dental history were recorded. Dental and radiographic examinations were performed. The presence of AP; the periapical index score; decayed, missing, and filled teeth; quality of restoration, and root canal treatment were evaluated. The influence of the medications the patients were taking on the prevalence of AP was also tested. RESULTS: The prevalence of AP was significantly lower in ALDs than in the control group at the patient (P = .019) and tooth level (P = .014). Smoking and age were associated with a significant increase in AP in cases and controls (P = .045 and P = .001, respectively). In both groups, endodontically treated teeth showed a higher prevalence of AP. CONCLUSIONS: Considering the limitations because of the observational nature of the study, the patients affected by ALDs liver diseases and undergoing treatment with immune suppressors (often associated with immune modulators) were found to exhibit a lower prevalence of AP.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Ideo F, Niazi S, Chessa L, et al. Prevalence of Apical Periodontitis in Patients with Autoimmune Liver Diseases on Immune Suppressants and Immune Modulators: A Cross-sectional Study. J Endod. 2024. PMID: 38527610. doi:10.1016/j.joen.2024.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。